Sprint Bioscience

A new possibility! ➡ Are you an energetic student with an interest in the Life Science business? Does sales make your heart tick faster? If so, you might be ready to be part of Sprint Bioscience's dynamic team as a Business Development Associate. For the right person, we offer an opportunity to, alongside studies, develop in an exciting role and gain practical experience in business development within Life science. Apply today: https://lnkd.in/gSdX9CBV https://lnkd.in/g3YzeRvi https://lnkd.in/gKWxE2yE #sprintbioscience #businessdevelopment #newjob #job #newcareer #nyttjobb #ledigatjänster 🔬 ⚗ 💊

Do you breathe science? Do you have an eye for structure-based design? Do you want to work in a multidisciplinary environment with cutting-edge science? Now we have an available position as Computational chemist to cover for a parental leave.  Apply today! ➡ ➡ https://lnkd.in/dMw35Je5 Curious about what it is like to work at #SprintBioscience? Find out through this link: https://lnkd.in/gyecnzk #compchem #computationalchemist #newjob #job #newcareer #nyttjobb #ledigatjänster

Sprint Bioscience will once more present results from the DISA program targeting the protein TREX1. The positive results from an in vivo proof-of-concept study show that treatment with the company's TREX1 inhibitors results in an improved immune response and inhibited tumor growth. The poster "Inhibition of TREX1 Increases Interferon Signaling and Reduces Tumor Growth In Vivo" is presented by Madhurendra Singh, PhD, Associate Principal Scientist, Sprint Bioscience at the conference "STING and TLR targeted therapy summit" in San Diego, 19 – 20 June 2024 by Hanson Wade Group. More information about the summit: https://lnkd.in/efnTJBA #hansonwade #sprintbioscience #sting #trex1 #oncology #immunooncology #drugdevelopment #newtherapies

Sprint Bioscience's CEO Johan Emilsson participated at "Aktiedagarna" in Stockholm, a two-day investor event arranged by Aktiespararna (Shareholders association) with company presentations and subsequent Q&A sessions (in Swedish). The recording from the event is now available. #sprintbioscience #investment #drugdevelopment #cancer 🎞 https://lnkd.in/dzgiCe7Q

Sprint Biosciences CEO Johan Emilsson will present the company at "Aktiedagarna" in Stockholm on Tuesday, June 11 at 17:15 (in Swedish). Aktiedagarna is a two-day investor event arranged by Aktiespararna (Shareholders association) with company presentations and subsequent Q&A session. You can find more information about the program through this link: https://lnkd.in/dtuewa_x

Want to know more about Sprint Bioscience's presence at the largest biotech event in the world? Bio International Convention #BIO2024 was held June 3–6 in San Diego, USA, and Sprint Biosciences' CEO Johan Emilsson talks about his impressions and focus going forward in a Q&A to be found on our website: https://lnkd.in/dDQTKvi4 #sprintbioscience #drugdevelopment #newtherapies #oncology #immunooncology #cancer 

Magnificent days at the BIO International Convention: Sprint Bioscience trio CEO Johan Emilsson CBO Anne-Marie Wenthzel and CSO Martin Andersson are maintaining good cardio keeping all the timeslots for the one-to-one meetings. Busy networking and insightful talks make #BIO2024 a well-executed convention as always. Since today, June 6th, is Sweden’s National Day, we take the opportunity to remind you about the upcoming BIO-Europe in our capital later this year: https://lnkd.in/dtwEEHWn  Come and meet us in Stockholm, Sweden! 🇸🇪 #BIO2024 #drugdevelopment #newtherapies #oncology #immunooncology #cancer #TREX1 #NNMT #STK25 #NASH #MASH

Vladimir Talibov from Sprint Bioscience participated in a panel discussion at the 22nd Annual Drug Discovery Summit & Discovery Chemistry Europe in Basel: a conference organized by Oxford Global https://lnkd.in/g9Arch2F. The topic for the panel discussion was Accelerating DMTA Cycle. A great opportunity to learn more about new approaches and strategies for small molecule drug discovery. #OxfordGlobal #drugdiscovery #drugdevelopment 

Sprint Bioscience had the pleasure of welcoming Cancerfonden (The Swedish Cancer Society) to our facilities. In a fruitful exchange of information, Cancerfonden presented its fantastic work. We guided them through the various phases of drug development, both in theory and how it looks in practice in our labs when we develop new cancer drugs - something we are both passionate about! A heartfelt thank you to everyone involved for their insights, enthusiasm, and dedication to the fight against cancer. #tillsammansmotcancer #cancer #oncology #drugdevelopment #newtherapies